This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
How DanioLabs has evolved its relationship with the CIMR
Go to paperABSTRACT: The commonest interaction of industry with academia is as the passive recipie…

I have posted a series of free biotechnology training videos at BiotechU.com . The course is derived from my textbook, Building

This spring has been a busy one for book launches — I have one final book to announce: The Success

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
A maturing industry: Strategic patenting trends, US and academic dominance, and the global biotechnology landscape
Go to paperABSTRACT: Patent analytical da…

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?

The 1980 Supreme Court case of Diamond v. Chakrabarty was transformative for the biotechnology industry. It saw the Supreme Court

In a recent post at In the Pipeline, Derek Lowe answers a reader’s question about how best to promote drug

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Festo: The plague continues
Go to paperABSTRACT: This paper reviews the law on the doctrine of equivalence and prosecution history estoppel and explores ho…

This is a guest post by Steve Sapletal,  a director in West Monroe Partners‘ M&A practice. Do you have a response to